This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of IPOL VIAL 5ML, a pharmaceutical product, with a potential value of $10,673.50 and a completion date of January 30, 2024. This delivery order is part of a larger, single-award indefinite delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of IPOL VIAL 5ML medical products. The $1,796.20 contract has an ultimate completion date of August 23, 2022. Amerisourcebergen Drug Corp, through its Corporate Office Division, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, which has a potential value of $2,134.70, is for the delivery of IPOL VIAL 5ML pharmaceutical products to support military treatment programs and facilities. The contract does not have a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,802.00, is for the delivery of IPOL VIAL 5ML medical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $42,694.00 firm fixed-price order is for the supply of 4564557634 IPOL VIAL 5ML, a pharmaceutical product, with a period of performance ending on May 10, 2024. Amerisourcebergen holds a single-award IDC with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which...
This is a firm fixed-price delivery order award to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4565244124 IPOL VIAL 5ML, with a ceiling value of $2,461.60 and a period of performance through July 25, 2024. Amerisourcebergen is a for-profit organization that holds several indefinite delivery contracts (IDCs) with the DLA and Department of Justice,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IPOL VIAL 5ML medical products. The contract has a ceiling value of $41,082.83 and an ultimate completion date of September 5, 2024. It is a firm-fixed-price contract type and is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a $2,561.64 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA). The contract is for the provision of IPOL VIAL 5ML, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to efficiently procure a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566174748 IPOL VIAL 5ML, a pharmaceutical product, with a total ceiling value of $21,347.00. The contract is a firm fixed-price, indefinite delivery contract with an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of IPOL VIAL 5ML, a pharmaceutical product, with a ceiling value of $2,134.70. The contract has an ultimate completion date of October 7, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) vehicle between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...